科学家开发针对乳腺癌的注射式水凝胶,在测试中将肿瘤减少75%。 Scientists develop injectable hydrogel that targets breast cancer, reducing tumors by 75% in tests.

IIT Guwahati和Bose Kolkata研究所的科学家创建了一种注射式水凝,将抗癌药物直接送到乳腺癌肿瘤,减少副作用。 Scientists at IIT Guwahati and Bose Institute Kolkata have created an injectable hydrogel that delivers anti-cancer drugs directly to breast cancer tumors, reducing side effects. 水文凝胶是由超短的皮片制成的,并释放出药物,以适应肿瘤的特定条件。 The hydrogel is made of ultra-short peptides and releases drugs in response to tumor-specific conditions. 在老鼠试验中,水凝体在18天内将肿瘤大小减少了75%,但不会对其他器官产生副作用。 In mouse trials, the hydrogel reduced tumor size by 75% in 18 days without causing side effects to other organs. 该小组计划开展进一步研究和最终临床试验,以探索其用于其他癌症的情况。 The team plans further studies and eventual clinical trials to explore its use for other cancers.